TrialNet functions within the Barbara Davis Center (BDC). The Research Division of the Barbara Davis Center brings together the collective expertise of basic and clinical scientists in areas of Immunology, Cell and Developmental Biology, Molecular Biology, Biochemistry, and Genetics.
Our faculty address fundamental questions relating to the etiology and pathogenesis of diabetes, including analysis of the molecular targets of autoimmunity, the role of the innate immune system, and the immunogenetics of type 1 diabetes in man. Together these are leading to the development of new biomarkers of disease risk and progression, and new approaches for clinical therapy and prevention of type 1 diabetes.
Research within the division is largely laboratory based and incorporated into ~30,000 square feet of dedicated ‘wet-lab’ space on the fourth floor of the Barbara Davis Center building on the Anschutz Medical campus of the University of Colorado.
The modern open plan laboratories incorporate dedicated facilities for human tissue cell culture, advanced microscopy and flow cytometry, and a GMP facility for the generation of cellular and immunological therapeutic reagents under stringent FDA approved conditions.
BDC researchers are affiliated with multiple international programs including TEDDY (The Environmental Determinants of Diabetes in the Young), T1DGC (Type 1 Diabetes Genetics Consortium), TRIALNET, and ITN (Immune Tolerance Network).
The research interests of current faculty can be accessed through the links to their individual homepages.
Research Division Faculty
Clinical Division Faculty
Research Division Telephone (No patient/clinical inquiries, please): 303.724.6836
Research Division Grants Coordinator & Administrator: Kathryn Gray